Theoretically, which of the following could be used as a "screening biomarker" for Alzheimer's Disease (something you test for to see if the disease is present)? 1. Presence of hyperphosphorylated Tau. 2. Presence of 42aa B-amyloid peptide. 3. Amount of acetylcholine production. 4. Amount of glutamate production. O A. 1, 2 and 3 OB. 1 and 3 O C. 2 and 4 D. 4 only E. All of 1, 2, 3, and 4 are correct

Theoretically, which of the following could be used as a "screening biomarker" for Alzheimer's Disease (something you test for to see if the disease is present)? 1. Presence of hyperphosphorylated Tau. 2. Presence of 42aa B-amyloid peptide. 3. Amount of acetylcholine production. 4. Amount of glutamate production. O A. 1, 2 and 3 OB. 1 and 3 O C. 2 and 4 D. 4 only E. All of 1, 2, 3, and 4 are correct

Essentials of Pharmacology for Health Professions

7th Edition

ISBN:9781305441620

Author:WOODROW

Publisher:WOODROW

Chapter17: Anti-infective Drugs

Section: Chapter Questions

Problem 20CRQ

See similar textbooks

Similar questions

Exposure to the compound below is most effectively treated with? CI CI N do= O-P O CH3 CH3 Itranscript O A. atropine & trimethaphan O B. edrophonium and methacholine OC. atropine & pralidoxime O D. pilocarpine & pralidoxime O E. neostigmine OF. IV bolus of acetylcholine
What is the relative activity of the following mineralocorticoid drugs? A. A>C>B>D B. A>B>C>D C. C>A>D>B D. D>C>B>A E. C>B>A>D
What is Prader–Willi syndrome? a. A genetic disorder characterized by loss of appetite b. Fat accumulation in the liver of leptin-resistant patients c. A failure to adapt to alternating periods of excess and inadequate energy intake d. A genetic disorder resulting in obesity e. Altered receptor activity for ghrelin
3) Cytokinetics is a Bay Area pharmaceutical company that has developed a drug called Tirasemtiv for the treatmentof motor disorders including ALS (amyotrophic lateral sclerosis) and myasthenia gravis. Tirasemtiv acts on skeletal muscle troponin and increases its affinity for calcium. a. Recall the role of calcium in muscle contraction. Describe what would happen if you gave a control patientTirasemtiv. Be sure to include what the effect would be and what you would want to measure to figure outthe difference in activity before and after Tirasemtiv administration. b. In ALS, there is loss of upper and lower motor neurons. In myasthenia gravis, circulating antibodiesblock acetylcholine receptors on the muscle. Describe what motor deficits you would expect to see inpatients with these diseases. c. Describe how you think Tirasemtiv would be useful in the treatment of ALS and myasthenia gravis.
1. Jesse age 27 complaints of muscle spasm, sweating abdominal pain and diarrhea. You know that her temperature is 101, pulse is 120 and her BP is 186/92. In reviewing her medications you note but she is taking fluoxetine (Prozac) and Sertraline (Zoloft), which life threatening events may she be experiencing? a. Neuroleptic malignant syndrome b. Monamine oxidase crisis c. Serotonin syndrome d. Hyperpyrexia
What proportion of all drugs prescribed · act on G-protein-coupled receptors? a. about 1/3 b. about 1/2 O c. about 3/4 d. about 1/4 e. about 2/3
1a.Arrange these ligands in their order of potencies(high to low) 1b. Choose an appropriate concentration of Propranolol needed to block 50% of epinephrine or isoproterenol induced cAMP production via adrenergic receptors expressed in a cell culture model system. 1c. Which of the following has more affinity to bind to adrenergic receptors? And why?I. EpinephrineII. IsoproterenolIII. Propranolol
Which of the following peptides acts as the bodys endogenous analgesic? Choices A.Tyr-Glu-Glu-Phe-Leu B.Tyr-Gly—Gly-Phe-Met C.Glu-Cys-Gly D.Gly-Cys-Glu
Identify the partial sequence of events that occurs after the insulin binds to its receptor. 1. Phosphorylation of insulin receptor substrate (IRS-1) 2. Activation of the receptor tyrosine kinase activity 3. Activation of phosphodiesterase 4. Activation of phospholipase C 5. Phosphorylation of phosphatidylinositol 6. Activation of phosphatidylinositol-3 -kinase (P1-3 kinase) 7. Binding of Grb 2 8. Activation of a phosphatase 9. Dephosphorylation of pyruvate kinase 10. phosphorylation of pyruvate kinase 2-7-1-4-3-9 1-7-3-5-6-8 2-1-6-5-8-9 2-7-1-6-5-8-9 2-7-4-6-1-8-10
"hich of the following statements is true of the differences between methohexital and midazolam? Multiple Choice Midazolam produces analgesia at small doses whereas methohexital produces amnesia at anesthetic doses. Midazolam induces anesthesia quickly, but methohexital does not. Methohexital has a specific receptor antagonist but midazolam does not. Midazolam is available for rectal administrątion, whereas methohexital is administered intravenously.
Select All statements that are TRUE regarding the effects of administering a molecule that is a precursor for the synthesis of a neurotransmitter A. Temporarily compensate for neuron cell death by increased release of the neurotransmitter (ex. L-dopa used as treatment for Parkinson’s disease) B. Increase the rate of synthesis of that neurotransmitter C. Block the reuptake of the neurotransmitter back into the axon terminal D. Immediately alter then number of postsynaptic receptors E. Act as an indirect antagonist by activating autoreceptors
The discovery of endogenous ligands that act on barbiturate binding sites and the ability to modulate these signals would benefit individua OA. Suffer from personality disorders O B. Suffer from seizures or increased neuronal activity OC. Suffer from decreased muscle tone O D. Suffer from memory loss